SCHEMBL4531442

SCHEMBL4531442

OCCOCCSC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4804833 0.98 KIF11 (0.50) KIF11
SCHEMBL4530986 0.98 KIF11 (0.50) KIF11
SCHEMBL9889271 0.85 KIF11 (0.45) KIF11
SCHEMBL4534194 0.85 KIF11 (0.45) KIF11
SCHEMBL4807284 0.84 KIF11 (0.55) KIF11
SCHEMBL4022115 0.82 KIF11 (0.67) KIF11
SCHEMBL17170545 0.81 KIF11 (0.47) KIF11
SCHEMBL22612072 0.81 KIF11 (0.65) KIF11
SCHEMBL22612073 0.81 KIF11 (0.65) KIF11
SCHEMBL22612075 0.81 KIF11 (0.65) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099044-A1 Nanoparticles and Method to Control Nanoparticle Spacing OREGON, UNIVERSITY OF 2009-04-16 US disclosed
WO-2006127675-A2 NANOPARTICLES AND METHOD TO CONTROL NANOPARTICLE SPACING STATE OF OREGON ACTING BY & THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099044-A1 Nanoparticles and Method to Control Nanoparticle Spacing ICAM1, L1CAM, EPCAM KIF11 713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.